Related Experiment Video
Updated: May 5, 2026
08:24
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
2.2K
Copper Overload Affects α-Synuclein Clearance Mechanisms in a Parkinson's Disease In Vitro Model
Debora Musarò1,2, Marina Damato2, Chiara Coppola2
1Laboratory of Clinical Proteomic, "V Fazzi" Hospital, Lecce, Italy.
Advanced Biology
|May 4, 2026
Summary
Copper overload impairs the clearance of alpha-synuclein, a key protein in Parkinson's disease (PD). This disruption affects cellular waste removal systems, leading to protein buildup and advancing our understanding of PD's molecular basis.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Parkinson's disease (PD) involves dopaminergic neuron loss and alpha-synuclein aggregation.
- Copper is an essential trace element implicated in PD pathogenesis and alpha-synuclein aggregation.
Purpose of the Study:
- To investigate the impact of copper overload on alpha-synuclein clearance pathways.
- To examine the effects on autophagy and the ubiquitin-proteasome system (UPS) in neuronal cells.
Main Methods:
- Utilized dopaminergic SH-SY5Y neuroblastoma cells.
- Assessed autophagy markers (Beclin-1, LC3-II) and UPS function.
- Investigated alpha-synuclein aggregation using immunofluorescence.
Main Results:
- Copper exposure enhanced autophagosome formation but impaired autophagic flux.
- Copper increased polyubiquitinated proteins, indicating UPS dysfunction.
- Observed accumulation and aggregation of phosphorylated alpha-synuclein, particularly in neurites.
Conclusions:
- Copper dyshomeostasis contributes to impaired alpha-synuclein clearance via autophagy and UPS.
- Disruption of these clearance pathways by copper overload advances understanding of PD molecular mechanisms.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28